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Background
HIV+ men who have sex with men (MSM) are at
increased risk of developing anal squamous cell carci-
noma. High-grade anal intraepithelial neoplasia (HG-AIN
or AIN2/3) is the consequence of persistent infection with
high-risk human papillomaviruses and is a precursor to
cancer. No biomarkers exist to identify patients with HG-
AIN at risk of malignant progression. We investigated two
candidate biomarkers of genomic instability, gamma-tubu-
lin and 53BP1, in a series of anal biopsies from HIV+
MSM by immunofluorescence microscopy. Gamma-tubu-
lin staining is used to assess centrosome abnormalities as
a potential source of cell division errors and aneuploidy,
while staining for 53BP1 nuclear foci reflects the presence
of DNA double strand breaks.
Materials and methods
Anal biopsies were obtained from HIV+ MSM under-
going high-resolution anoscopy and reported using the
Bethesda 2001 classification system as AIN1 through
3 or carcinoma. Normal colonic tissue served as con-
trols. The percentage of cells with abnormal centrosome
number (more than two per cell) and DNA damage-
associated 53BP1 foci was assessed and correlated with
the histopathological diagnosis. Eighty-eight biopsies
were stained for gamma-tubulin, and ninety biopsies
were stained for 53BP1.
Results
The mean percentage of cells with abnormal centro-
somes was 1.5% in AIN1, 1.3% in AIN2, and 0.9% in
AIN3. No controls showed centrosome aberrations.
A single biopsy diagnosed as carcinoma contained 16.1%
cells with abnormal centrosomes. The mean percentage
of cells with abnormal 53BP1 foci was 2.5% in controls,
17% in AIN1, 18.5% in AIN2, and 5.2% in AIN3. Higher
levels of abnormal 53BP1 foci were seen in AIN1 and
AIN2 compared to controls based on pair-wise compari-
sons between control and AIN1 (p=0.0008) and control
and AIN2 (p=0.0030) using the Mann Whitney test.
Lower levels of 53BP1 foci were seen in AIN3 compared
to AIN1 and 2 based on pair-wise comparisons between
AIN1 versus AIN3 (p=0.0034) and between AIN2 versus
AIN3 (p=0.0056).
Conclusion
The levels of centrosome aberrations were generally low
in AIN1 through 3 and were increased in carcinoma,
suggesting that centrosome abnormalities may not occur
until malignant progression. DNA damage-associated
53BP1 foci were increased in AIN1 and 2 when com-
pared to controls, whereas AIN3 showed lower levels of
53BP1 foci. These results are consistent with previous
studies suggesting that the DNA damage response
represents an early barrier against malignant progres-
sion. Further prospective studies assessing the predictive
value in particular of 53BP1 as a biomarker in HPV-
associated anal neoplasia are warranted.
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